There are many news articles on how COVID-19 will change the world. Healthcare systems are changing rapidly, and our means of undertaking assessments of value will also need to change. HTA is not immune to COVID-19, but it can and will adapt.
New commentary: Impact of a Global Pandemic on Health Technology Assessment
More from UncategorizedMore posts in Uncategorized »
- New Review by One Health Consulting: International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making
- Check the new publication by leaders in MENA: Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status
- Managed entry agreements- the ultimate solution for reimbursement
- Why do we need HTA?